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Synovial tissue can display an inflammatory response in the presence of OA. There is increasing interest to better understand the
role of inflammation in OA, particularly with regard to those who require joint replacement. A systematic review of inflammatory
synovitis in OA of literature databases was undertaken from their inception until October 14, 2014. Independent critical appraisal
of each study was undertaken using the CASP appraisal tool. From a total of sixty-six identified citations, twenty-three studies were
deemed eligible for review. The studies presented moderate to strong methodological quality. Strong correlation was identified
between histological and imaging synovitis severity. Correlation was weaker between clinical symptoms and imaging and/or
histological synovitis severity. There was little consensus, with regard to expressed cytokines and chemokines at the different
stages of OA disease progression. Few studies investigated the influence of inflammatory synovitis on the outcome of major joint
replacement. Research into inflammatory synovitis in OA is an emerging field. Longitudinal studies applying proven imaging
modalities, histological analysis, and longer follow-up are required in order to further define our understanding of the role of
synovitis in the pathogenesis of OA and its effects on outcomes following major joint replacement.
1. Introduction
People with osteoarthritis (OA) typically experience joint
pain, stiffness, and swelling.The condition causes progressive
physical disability and pain. The aetiology of OA is multifac-
torial [1], with both systemic and local biomechanical factors
identified [2]. The prevalence of OA in the US is estimated
at nearly 27 million people and accounts for 25% of visits
to primary care physicians [3]. In the hip and knee, OA
often causes progressive joint damage with growing numbers
requiring joint replacement surgery [4].
In contrast to rheumatoid arthritis (RA), OA has con-
ventionally been considered a noninflammatory condition.
This may be simplistic. The term arthritis was coined to
describe joint inflammation. Trainees have long been taught
that synovial inflammation and joint effusion are common
in the early stages of degenerative joint disease and synovial
proliferation is a common finding in patients undergoing
arthroscopy and arthroplasty [5]. Magnetic Resonance Imag-
ing (MRI) has identified synovitis in early OA, even in the
absence of the relevant clinical findings [6]. In the wake of
recent successes in the treatment of RA, attention is now
turning to the possibility of medical treatments to suppress
or slow the inflammatory elements of OA.
At a cellular level, the role of immune cells and cytokines
is well established. Infiltration ofmacrophages and perivascu-
lar T and B lymphocytes is described in early and advanced
disease [7].Themain cytokines identified inOApathogenesis
are Interleukin-1𝛽 (IL-1𝛽) and Tumour Necrosis Factor 𝛼
(TNF𝛼) [8]. It is known that these cytokines can mediate
the production of other cytokines, matrix metalloproteinases
(MMP), and proteases with effects on T lymphocytes, chon-
drocytes, and synovial cells.
The purpose of this systematic review is to identify
studies demonstrating the inflammatory changes that are
frequently observed in patients undergoing joint arthroplasty
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Table 1: Summary of the critical appraisal score (full papers only).
Study CASP criterion number
1 2 3 4 5 6 7 8 9 10 11 Total
Benito et al., 2005 [22] Y Y Y Y Y N Y Y Y Y Y 10
De Lange-Brokaar et al., 2014 [10] Y Y Y Y Y Y Y Y Y Y Y 11
Lambert et al., 2014 [28] Y Y Y Y Y Y Y Y Y Y Y 11
Liu et al., 2010 [11] Y Y Y N N N Y N Y Y N 6
Oehler et al., 2002 [27] Y Y N Y N N Y Y Y Y Y 8
Østergaard et al., 1998 [9] Y Y Y Y Y Y Y Y Y Y Y 11
Scanzello et al., 2009 [24] Y Y Y Y Y Y Y Y Y Y Y 11
Smith et al., 1997 [26] Y Y N Y N N Y Y Y Y Y 8
Takase et al., 2012 [16] Y Y N N N N Y Y Y Y Y 7
Tanavalee et al., 2011 [30] Y Y Y Y N N Y Y Y Y N 8
Waldstein et al., 2014 [17] Y Y Y Y Y N Y Y Y Y N 9
Walther et al., 2001 [15] Y Y Y Y Y Y Y Y Y Y Y 11
Walther et al., 2002 [14] Y Y Y Y Y Y Y Y Y Y Y 11
Y: yes; N: no.
(1) Did the study address a clearly focused issue?
(2) Was the cohort recruited in an acceptable way?
(3) Was the exposure accurately measured to minimize bias?
(4) Was the outcome accurately measured to minimize bias?
(5) Have the authors identified all important confounding factors?
(6) Have they taken account of the confounding factors in the design and/or analysis?
(7) Was the follow-up of subjects complete enough?
(8) Was the follow-up of subjects long enough?
(9) Do you believe the results?
(10) Can the results be applied to the local population?
(11) Do the results of this study fit with other available evidences?
and the influence of the synovial response on disease progres-
sion and treatment outcome.
2. Material and Methods
2.1. Search Strategy. One reviewer (Sherif Hosny) performed
a PRISMA compliant search of the electronic databases
EMBASE and Medline and Cochrane via the Ovid platform
from inception until October 14, 2014. In addition, grey
literature and trial registry searches were conducted using
the WHO International Clinical Trials Registry Platform,
Current Controlled Trials, and the United States National
Institute of Health Trials Registry. The NIHR Clinical
Research Portfolio Database was searched as was the ISI
Web of Knowledge and OpenGrey System for Information
on Grey Literature in Europe. The search terms adopted
included “exp Synovitis” OR “spondyloarthropathy/” OR
“exp HLA-B27 Antigen/” OR “synovitis.mp.” OR “seroneg-
ative.mp.” AND exp arthroplasty/OR hip replacement∗.mp
OR knee replacement∗.mp OR arthroplasty.mp. OR joint
replacement∗.mp. An English language restriction was
applied. Additionally, the reference lists of all identified
articles were screened for additional papers.
2.2. Inclusion/Exclusion Criteria. Study identification was
initially performed by one reviewer (Sherif Hosny) and then
verified by another (Francesco Strambi) after consulting the
titles and abstracts.The search strategywas run and identified
articles were exported as titles and abstracts. Papers were
then retrieved in full and a further round of relevancy
screeningwas undertaken by the two reviewers (Sherif Hosny
and Francesco Strambi). Studies presenting nonoriginal data,
such as reviews, editorials, opinion papers, and letters to the
editor, were excluded. Conference presentation abstracts with
no retrievable data were excluded. Studies with nonhuman
subjects were excluded. Studies in paediatric subjects were
excluded. For all papers initially considered eligible, full texts
were ordered, and those satisfying the eligibility criteria were
included in the final review.
2.3. Methodological Appraisal. All studies identified in the
search strategy and included in this review were assessed
using the (Critical Appraisal Skills Programme) CASP cohort
study appraisal tool. Eleven critical appraisal questions were
asked of each paper. These are itemized in Table 1 and assess
the internal and external validity of each included study. Each
study was evaluated against this checklist by one reviewer
(Sherif Hosny) and verified by a second (Francesco Strambi).
Any disagreements were resolved through consensus.
3. Results
3.1. Search Results. Initial search yielded 3165 papers from
the search strategies. These were all exported as titles and
abstracts. After screening the titles and abstracts for rel-
evancy, 1323 citations were excluded. A further round of
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Records identified through
database searching (OvidSP)
Additional records identified
through grey literature
Records after duplicates removed
Records screened title Records excluded
Full-text articles assessed
for eligibility
Full-text articles excluded
Studies included in
qualitative synthesis
(n = 2288) (n = 877)
(n = 1373)
(n = 1323)
(n = 1373)
and abstract
(n = 66)
(n = 50)
(n = 16)
Figure 1: PRISMA flowchart.
relevancy screening was undertaken and 66 papers were
identified for retrieval. A final tally of 16 papers were reviewed
(Figure 1).
3.2. Methodological Quality. The results of the CASP critical
appraisal are shown in Table 1 and presented moderate to
strong methodological quality. The included papers always
addressed a focused issue and recruited in a replicable and
acceptable way. All papers described their cohort’s charac-
teristics and trial eligibility criteria. Exposure and outcome
bias was reasonably well controlled. All studies provide
sufficient reporting to permit generalizability of their results
to a clinical population. However, recurrent limitations in
the evidence base included poor identification of important
confounders (𝑛 = 5) and not accounting for confounding
variables in the design of the study (𝑛 = 7). Some studies
reported results that contradicted other available evidences or
there was no other published evidence to compare to (𝑛 = 3).
3.3. Study Characteristics. A summary of the included study
characteristics is presented in Table 2. Eight studies were
concerned with imaging of the synovitis using either MRI or
ultrasound and the correlation of imaging with histopatho-
logical grading. Seven studies were concerned with detailed
histological analysis of the synovitis. One study evaluated
outcomes associated with synovitis.
3.4. Clinical Findings
3.4.1. Correlation of Synovitis Severity in Imaging with Histo-
logical Severity. Three authors found significant correlations
between synovitis, as seen on MRI, and histological severity
grading [9–11]. In the first of these, Østergaard et al. [9] used
gadolinium enhanced MR scanning and showed that while
dynamic MRI could distinguish knees with and without syn-
ovial inflammation, it could not differentiate between mod-
erate and severe inflammation. De Lange-Brokaar et al. [10]
used 3 T gadolinium enhanced MR scanning in 41 patients,
undergoing Total Knee Replacement (TKR) or arthroscopy,
and found significant correlation between total synovitis
grade using the Guermazi grading system [12] and the total
histology grade using amodifiedKrenn system [13]. Similarly
Liu et al. [11] found significant correlation between gadolin-
ium enhanced MRI synovitis score and total synovitis score
on histological analysis using a similar grading system. A
positive associationwas also foundwithmacroscopic features
such as neovascularisation, hyperplasia, and villi formation.
Power Doppler US (PDUS) was the focus of three studies
in the literature [14–16]. Walther et al. [14, 15] used PDUS to
image osteoarthritic hips and knees prior to arthroplasty. In
both joints, PDUS proved to be reliable in qualitative grading
of the vascularity of the synovial tissue as graded after staining
with haematoxylin and eosin or factor VII (immunohisto-
chemistry). Interestingly, there was a correlation between the
thickness of the synovial membrane and the PDUS signal but
no correlation between synovial proliferation and effusion.
In a study by Takase et al. [16], grey scale ultrasound scan
(GSUS), PDUS, and contrast enhanced MRI were evaluated
against histopathology findings in OA and RA patients
undergoing TKR. In this study, cluster of differentiation 68
(CD68) was used as a marker for inflammatory cell infil-
trate, antigen Ki-67 for synovial lining cell thickness, and
cluster of differentiation 31 (CD31) for vascularity. All three
imaging modalities showed a positive correlation with the
histopathological total synovitis score with PDUS showing
the highest correlation. In contrast, only PDUS and MRI
showed high correlation with the immunohistochemical
parameters investigated.
Conversely, Waldstein et al. [17], using 1.5 T or 3 T
MRI, without contrast, found no correlation between MRI
synovitis grades and histopathological grades using validated
scoring systems. The WORMS system [12] was used for MRI
synovitis grading and the Krenn system [13] for histopatho-
logical grading. While the correlation between imaging and
histological synovitis was not the core focus of this study,
the authors did find a relationship between intra-articular
inflammation and cartilage properties (see Section 3.4.4).
The use of MRI, MRS, and PDUS has been described
in recent studies to measure synovitis, which could account
for some differences between observed studies. It is therefore
important that future studies utilise standardised tools for
measuring synovitis radiographically. It has been suggested
that MRI techniques, especially with contrast, could be
optimal because standardised views can be reproduced and
synovitis can bemost easily differentiated fromother vascular
structures.
3.4.2. Correlation of Histological or Imaging Severity with
Clinical Findings. Only a few workers have tried to correlate
synovitis with pain. De Lange-Brokaar et al. [18] found
a significant correlation between MRI synovitis score and
4 Arthritis
Ta
bl
e
2:
St
ud
y
de
sig
n
an
d
ch
ar
ac
te
ris
tic
s.
St
ud
y
O
A
/R
A
Su
rg
ic
al
in
te
rv
en
tio
n
Im
ag
in
g
m
od
al
ity
Sy
no
vi
al
tis
su
es
co
rin
g
M
ar
ke
rs
m
ea
su
re
d
Cl
in
ic
al
sc
or
in
g
sy
ste
m
Re
su
lt
Be
ni
to
et
al
.,
20
05
[2
2]
O
A
TK
R
or
ar
th
ro
sc
op
y
XR
N
/A
In
fla
m
m
at
or
y
ce
ll
in
fil
tr
at
e,
bl
oo
d
ve
ss
el
fo
rm
at
io
n,
an
gi
og
en
ic
fa
ct
or
s,
N
F-
kB
ac
tiv
at
io
n,
TN
F𝛼
,I
L-
1𝛽
,
CO
X-
1,
CO
X-
2,
an
d
fib
ro
bl
as
tl
ik
e
sy
no
vi
oc
yt
es
(F
LS
)
N
A
Ea
rly
O
A
tis
su
ee
xh
ib
ite
d
gr
ea
te
rl
in
in
g
la
ye
rt
hi
ck
ne
ss
an
d
gr
ea
te
rC
D
4+
T
ce
ll
an
d
CD
68
+
m
ac
ro
ph
ag
ei
nfi
ltr
at
io
n;
al
so
m
or
en
um
er
ou
sb
lo
od
ve
ss
els
an
d
V
EG
F
an
d
IC
A
M
-I
ex
pr
es
sio
n
an
d
gr
ea
te
r
nu
m
be
rs
of
ce
lls
pr
od
uc
in
g
TN
F𝛼
an
d
IL
-1
𝛽
;F
LS
fu
nc
tio
na
lly
sim
ila
ri
n
ea
rly
an
d
la
te
O
A
D
eL
an
ge
-B
ro
ka
ar
et
al
.,
20
13
(a
bs
tr
ac
t)
[1
8,
19
]
O
A
A
rt
hr
os
co
py
C
on
tr
as
t
en
ha
nc
ed
M
RI
G
ue
rm
az
ie
ta
l.
M
RI
sc
or
in
g
sy
ste
m
N
/A
VA
S
pa
in
Kn
ee
sy
no
vi
tis
se
ve
rit
y
on
M
RI
co
rr
el
at
ed
w
ith
m
ac
ro
sc
op
ic
an
d
m
ic
ro
sc
op
ic
hi
sto
lo
gi
ca
ls
yn
ov
iti
sf
ea
tu
re
sb
ut
no
t
w
ith
VA
S
pa
in
D
eL
an
ge
-B
ro
ka
ar
et
al
.,
20
13
(a
bs
tr
ac
t)
[1
8,
19
]
O
A
A
rt
hr
os
co
py
or
TK
R
C
on
tr
as
t
en
ha
nc
ed
M
RI
G
ue
rm
az
ie
ta
l.
M
RI
sc
or
in
g
sy
ste
m
N
/A
D
iff
er
en
tp
at
te
rn
so
fk
ne
es
yn
ov
iti
sw
er
e
co
rr
el
at
ed
to
kn
ee
pa
in
sc
or
in
g
sy
ste
m
s
D
eL
an
ge
-B
ro
ka
ar
et
al
.,
20
14
[1
0]
O
A
A
rt
hr
os
co
py
or
TK
R
G
d-
D
O
TA
M
RI
3T
Kr
en
n
et
al
.s
ys
te
m
,
lin
in
g
ce
ll
la
ye
r,
sy
no
vi
al
str
om
a,
an
d
in
fla
m
m
at
or
y
in
fil
tr
at
e
gr
ad
ed
0–
3
N
/A
N
/A
Sy
no
vi
tis
se
ve
rit
y
on
M
RI
co
rr
el
at
ed
w
ith
m
ac
ro
-a
nd
m
ic
ro
sc
op
ic
fe
at
ur
es
of
sy
no
vi
tis
in
kn
ee
O
A
Li
an
g
et
al
.,
20
09
(a
bs
tr
ac
t)
[2
3]
O
A
TK
R
or
ar
th
ro
sc
op
y
or
A
nt
er
io
r
Cr
uc
ia
te
Li
ga
m
en
t
(A
CL
)
re
co
ns
tr
uc
tio
n
N
/A
Sy
no
vi
al
CD
31
,N
F-
xB
,
M
M
P-
1,
CO
X-
2,
IL
-1
𝛽
,
an
d
TG
F-
𝛽
JK
O
M
Sy
no
vi
um
M
M
P-
1,
CO
X-
2,
an
d
IL
-1
𝛽
ex
pr
es
sio
n
in
en
d
sta
ge
O
A
re
du
ce
d
in
co
m
pa
ris
on
to
th
os
eo
fp
ro
gr
es
siv
eO
A
;
ex
pr
es
sio
n
of
TG
F-
𝛽
in
th
es
yn
ov
iu
m
of
en
d
sta
ge
O
A
w
as
sig
ni
fic
an
tly
in
cr
ea
se
d
in
co
m
pa
ris
on
to
th
at
of
pr
og
re
ss
iv
eO
A
;
th
eM
M
P-
1,
IL
-1
𝛽
,a
nd
TG
F-
𝛽
ex
pr
es
sio
n
in
th
es
yn
ov
iu
m
sig
ni
fic
an
tly
co
rr
el
at
ed
w
ith
th
er
ad
io
gr
ap
hi
ca
nd
cli
ni
ca
l
m
an
ife
st
at
io
ns
of
kn
ee
O
A
La
m
be
rt
et
al
.,
20
14
[2
8]
O
A
TK
R
N
/A
Su
rg
eo
n
gr
ad
ed
m
ac
ro
sc
op
ic
cr
ite
ria
by
Ay
ra
le
ta
l.
no
rm
al
,
re
ac
tiv
e,
an
d
in
fla
m
ed
Cy
to
ki
ne
s,
ch
em
ok
in
es
,
en
zy
m
es
,a
na
bo
lis
m
,
ca
ta
bo
lis
m
,a
nd
an
gi
og
en
es
is
co
m
po
un
ds
N
/A
In
fla
m
m
at
io
n,
ca
rt
ila
ge
m
et
ab
ol
ism
,W
nt
sig
na
lli
ng
,a
nd
an
gi
og
en
es
is
pa
th
w
ay
s
w
er
eu
pr
eg
ul
at
ed
in
ar
ea
so
fi
nfl
am
ed
sy
no
vi
um
Arthritis 5
Ta
bl
e
2:
C
on
tin
ue
d.
St
ud
y
O
A
/R
A
Su
rg
ic
al
in
te
rv
en
tio
n
Im
ag
in
g
m
od
al
ity
Sy
no
vi
al
tis
su
es
co
rin
g
M
ar
ke
rs
m
ea
su
re
d
Cl
in
ic
al
sc
or
in
g
sy
ste
m
Re
su
lt
Li
u
et
al
.,
20
10
[1
1]
O
A
TK
R
G
d-
M
RI
1.5
T
H
ist
ol
og
ic
al
pa
ra
m
et
er
s
0–
3
N
/A
JK
O
M
,V
A
S,
an
d
W
O
M
AC
N
ei
th
er
sy
no
vi
tis
no
rG
d-
M
RI
sc
or
e
co
rr
el
at
es
w
ith
pa
in
VA
S
sc
or
eo
r
W
O
M
AC
;t
he
y
on
ly
co
rr
el
at
ed
w
ith
JK
O
M
sc
or
e
O
eh
le
re
ta
l.,
20
02
[2
7]
O
A
TK
R
or
ar
th
ro
sc
op
y
N
/A
Sc
or
ed
0–
4,
im
m
un
oh
ist
oc
he
m
ist
ry
In
fla
m
m
at
or
y
in
fil
tr
at
es
N
/A
4
su
bt
yp
es
of
sy
no
vi
op
at
hy
ch
ar
ac
te
ris
ed
;
hy
pe
rp
la
st
ic
in
ea
rly
O
A
;i
nfl
am
m
at
or
y
in
ea
rly
an
d
lat
eO
A
;fi
br
ot
ic
an
d
de
tr
itu
s
ric
h
in
la
te
O
A
Ø
ste
rg
aa
rd
et
al
.,
19
98
[9
]
O
A
an
d
RA
Kn
ee
ar
th
ro
sc
op
y
or
ar
th
ro
to
m
y
G
d-
D
TP
A
M
RI
1.5
T
H
ist
ol
og
ic
al
pa
ra
m
et
er
s
0–
3
N
/A
N
/A
D
yn
am
ic
M
RI
ca
n
be
us
ed
to
de
te
rm
in
e
sy
no
vi
al
in
fla
m
m
at
io
n
bu
tc
ou
ld
no
t
di
ffe
re
nt
ia
te
be
tw
ee
n
m
od
er
at
ea
nd
se
ve
re
in
fla
m
m
at
io
n
Sc
an
ze
llo
et
al
.,
20
09
[2
4]
O
A
TK
R
XR
N
/A
IL
-1
5,
IL
-6
,I
L-
1𝛽
,T
N
F𝛼
,
IL
-2
,I
L-
21
,M
M
P-
1,
an
d
M
M
P-
3
N
/A
Ly
m
ph
oc
yt
ic
in
fil
tr
at
es
fo
un
d
in
al
le
ar
ly
O
A
sp
ec
im
en
sb
ut
on
ly
in
so
m
ee
nd
sta
ge
sp
ec
im
en
s;
IL
-1
5
sig
ni
fic
an
tly
hi
gh
er
in
ea
rly
O
A
pa
tie
nt
s
Sm
ith
et
al
.,
19
97
[2
6]
O
A
TK
R
or
ar
th
ro
sc
op
y
N
/A
Sc
or
ed
0–
4,
im
m
un
oh
ist
oc
he
m
ist
ry
IL
-1
𝛼
,I
L-
1𝛽
,T
N
F𝛼
,a
nd
IL
-1
ra
N
/A
Sy
no
vi
al
m
em
br
an
ei
nfl
am
m
at
io
n
m
or
e
se
ve
re
w
ith
ad
va
nc
ed
O
A
Ta
ka
se
et
al
.,
20
12
[1
6]
O
A
an
d
RA
TK
R
G
SU
S,
PD
U
S,
an
d
G
d-
D
TP
A
1.5
T
M
RI
O
M
ER
AC
T-
RA
M
RI
S
(0
–3
),
hi
sto
pa
th
ol
og
y
0–
3
Im
m
un
oh
ist
oc
he
m
ist
ry
CD
68
,K
i-6
7,
an
d
CD
31
N
/A
G
SU
S,
PD
U
S,
an
d
M
RI
co
rr
el
at
ed
w
ith
pa
th
ol
og
ic
al
to
ta
ls
yn
ov
iti
ss
co
re
;o
nl
y
PD
U
S
an
d
M
RI
sh
ow
ed
hi
gh
co
rr
ela
tio
n
w
ith
im
m
un
oh
ist
oc
he
m
ic
al
pa
ra
m
et
er
s
(C
D
68
fo
ri
nfl
am
m
at
or
y
ce
ll
in
fil
tr
at
e,
Ki
-6
7
fo
rs
yn
ov
ia
ll
in
in
g
ce
ll
th
ic
kn
es
s,
an
d
CD
31
fo
rv
as
cu
la
rit
y)
Ta
na
va
le
ee
ta
l.,
20
11
[3
0]
O
A
TK
R
N
/A
N
/A
Se
ru
m
CR
P,
ES
R,
an
d
IL
-6
A
m
er
ic
an
Kn
ee
So
ci
et
y
sc
or
ea
nd
kn
ee
su
rfa
ce
te
m
pe
ra
tu
re
Sy
no
ve
ct
om
y
at
th
et
im
eo
fT
KR
do
es
no
t
be
ne
fit
th
eo
ut
co
m
en
or
sh
or
te
n
th
e
du
ra
tio
n
of
th
ei
nfl
am
m
at
or
y
re
sp
on
se
W
al
th
er
et
al
.,
20
01
[1
5]
O
A
A
N
D
RA
TK
R
Po
w
er
D
op
pl
er
so
no
gr
ap
hy
(P
D
S)
Va
sc
ul
ar
ity
gr
ad
ed
1–
4
N
/A
N
/A
PD
S
re
lia
bl
ei
n
qu
al
ita
tiv
eg
ra
di
ng
of
sy
no
vi
al
tis
su
ev
as
cu
la
rit
y
in
kn
ee
s
W
al
th
er
et
al
.,
20
02
[14
]
O
A
an
d
RA
TH
R
PD
S
Va
sc
ul
ar
ity
gr
ad
ed
1–
4
N
/A
N
/A
PD
S
re
lia
bl
ei
n
qu
al
ita
tiv
eg
ra
di
ng
of
sy
no
vi
al
tis
su
ev
as
cu
la
rit
y
in
hi
ps
W
al
ds
te
in
et
al
.,
20
14
[1
7]
O
A
TK
R
M
RI
1.5
or
3T
W
O
RM
S
sc
or
in
g
sy
ste
m
;
Kr
en
n
et
al
.s
yn
ov
iu
m
gr
ad
in
g
sy
ste
m
,l
in
in
g
ce
ll
lay
er
,s
yn
ov
ia
l
str
om
a,
an
d
in
fla
m
m
at
or
y
in
fil
tr
at
e
gr
ad
ed
0–
3
Sy
no
vi
al
W
BC
co
un
t,
M
an
ki
n
ca
rt
ila
ge
gr
ad
in
g
sy
ste
m
;
ag
gr
eg
at
ea
nd
dy
na
m
ic
m
od
ul
us
ca
rt
ila
ge
bi
om
ec
ha
ni
cs
N
/A
C
ar
til
ag
em
ec
ha
ni
ca
lly
in
fe
rio
ri
n
kn
ee
s
w
ith
W
BC
>
15
0W
BC
s/
m
L
co
m
pa
re
d
to
kn
ee
sw
ith
<
15
0W
BC
s/
m
L;
M
RI
an
d
hi
sto
pa
th
ol
og
ic
sy
no
vi
tis
gr
ad
es
di
d
no
t
co
rr
el
at
ew
ith
ea
ch
ot
he
ro
ra
gg
re
ga
te
or
dy
na
m
ic
ca
rt
ila
ge
m
od
ul
us
6 Arthritis
pain level as recorded, on a visual analogue scale (VAS), in
knee osteoarthritis patients undergoing TKR or arthroscopy.
The same authors in an earlier paper [19] foundno association
between MRI synovitis score and pain. However, the earlier
study had fewer participants and included only patients due
for arthroscopy and not TKR. In the later work, the authors
reported a positive association between synovitis and pain as
measured by VAS or Knee Injury and Osteoarthritis Score
(KOOS) or Intermittent and Constant Osteoarthritis Pain
(ICOAP) scores. However, these findings depended on the
location of the synovitis within the knee. It was observed that
different synovitis locations correlated with different pain
scoring systems. In contrast, in a study of 34 Japanese patients
with OA requiring TKR, Liu et al. [11] found that neither
the synovitis scores evaluated by histological analysis nor
those by a gadolinium enhanced MRI scan were correlated
with pain as assessed on the VAS or the Western Ontario
and McMaster Universities Osteoarthritis Index (WOMAC)
score [20].They did however correlatewith the JapaneseKnee
Osteoarthritis Measure (JKOM) [21] score.
3.4.3. Early versus Late Osteoarthritis. Three studies have
investigated differences in synovial tissue inflammation in
early and late OA. Benito et al. [22] compared patients
with advanced OA, awaiting TKR, against patients with
early OA. Synovial tissue from early OA patients exhibited
greater lining layer thickness as well as greater intensity
of CD4+ T cell and CD68+ macrophage infiltration. Blood
vessels were more numerous as were vascular endothelial
growth factor (VEGF), a marker of vascular proliferation,
and intercellular adhesion molecule 1 (ICAM-I), expressed
on vascular endothelial cells. Greater numbers of cells pro-
ducing TNF𝛼 and IL-1𝛽 were seen in early OA. However,
fibroblast like synoviocytes were functionally similar in both
groups. In another study by Liang et al. [23], end stage OA
patients, undergoing TKR, were compared with Anterior
Cruciate Ligament (ACL) reconstruction patients. Matrix
metalloproteinase-1 (MMP-1), cyclooxygenase COX-2, and
IL-1𝛽 expression were significantly greater in those with
progressive OA as compared to those with end stage disease.
Transforming growth factor beta (TGF𝛽) expression was
found to be greater in end stage OA.
Conversely Scanzello et al. [24] found differences only
in IL-15 levels between early OA and late OA. Patients with
end stage OA undergoing TKR had significantly lower levels
than patients undergoing arthroscopy for meniscal tears. In
another study, Richardson et al. [25] compared levels of
Interleukin-8 (IL-8), IL-1𝛽, Interleukin-6 (IL-6), Interleukin-
10 (IL-10), TNF, and Interleukin-12 (IL-12) in synovial fluid
samples from OA, RA, and normal patients. Only IL-6 was
significantly higher in the RA andOA samples in comparison
to the normal group.
De Lange-Brokaar et al. [10] found that more patients
in their arthroplasty group showed inflammatory infiltrates
compared to their arthroscopy group. Furthermore, the
grades for both the lining layer and the inflammatory infil-
trate were significantly higher in the arthroplasty group. For
the stroma, no significant differences were identified between
the groups. These findings supported an earlier study by
Smith et al. [26] which showed synovial membrane inflam-
mation to be more severe, exhibiting a thicker lining layer,
increased vascularity, and more abundant inflammatory cell
infiltrate with advanced OA. Increased levels of IL-1𝛼, IL-1𝛽,
and TNF𝛼 were also seen with increased cartilage damage.
Oehler et al. [27] categorised the synoviopathy present in
OA into four distinct categories depending on the histomor-
phological features observed. In early OA, a mostly hyper-
plastic subtype was observed. This was distinguished from
other variants by its villous hyperplasia and relative absence
of inflammatory infiltrates, capsular fibrosis, and cartilage
and bone detritus. An inflammatory subtype, characterised
by synovial hyperplasia andmoderate lymphocytic infiltrates,
was seen in early and late OA.This subtype was also noted for
its lack of capsular fibrosis and cartilage debris. Late stage OA
was also seen in what were deemed detritus rich and capsular
fibrosis subtypes. These were characterised by cartilage and
bone debris and capsular fibrosis, respectively.
3.4.4. Cartilage Effects. In a biomechanical study of the effects
of inflammation on cartilage integrity, De Lange-Brokaar
et al. [18] found that lateral compartment cartilage was
mechanically inferior in knees undergoing TKR for OA in
the presence of a white cell count >150WBC/mL. These
cartilage samples had significantly reduced mean aggregate
and dynamic modulus when compared to samples taken
from knees with <150WBC/mL. However, in contrast to
the majority of other studies, Waldstein did not identify
any link between MRI synovitis grade and aggregate or
dynamic modulus or link between MRI synovitis grade and
histopathologic grade.
3.4.5. Gene Expression. Lambert et al. [28] identified 896
genes that were differently expressed between two areas
of synovial membrane from the same patient. In this
study, twelve patients undergoing knee replacement were
investigated. Synovial tissue was macroscopically categorised
according to the Ayral criteria [29] as either normal/reactive
or inflamed at the time of operation by the surgeon.
Genes for inflammatory cytokines, chemokines, anabolism
compounds, catabolism compounds, and angiogenesis com-
pounds were upregulated in areas of inflamed synovium
compared to uninflamed control areas. These key pathways
were related to inflammation, cartilagemetabolism,wingless-
related integration site (Wnt) signalling, and angiogenesis.
Specific compounds are listed in Table 3.
3.4.6. Outcomes. Tanavalee et al. [30] have investigated the
effect of synovectomy in TKR. In two similar groups for
which there was no observed difference in inflammatory
synovitis at operation, it was shown that synovectomy made
no difference neither to clinical outcome score, as measured
by the American Knee Society Score [31], or to serial postop-
erative inflammatory markers as measured by ESR, CRP, IL-
6, or mean skin temperature. As such, the authors concluded
that synovectomy at the time of TKR does not improve
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Table 3: Genes differentially expressed between normal/reactive and inflamed areas of synovium.
Compound Upregulated Downregulated
Inflammatory cytokines IL8, IL6, TNFRSF21, IFI30, TNFAIP6, and IRF8
Inflammatory chemokines CXCL5, CXCL6, CXCL16, CXCL2, and CXCL1
Inflammatory enzymes ALOX5AP, PLD1, ALOX5, PTGES, PLCB1,SOD2, TBXAS1, PI3, and PLA2G4A
Other inflammatory compounds TREM1, S100A9, OSM, and PPARG
Anabolism HAS1, BMP6, and COLL22A1
COL1A2, VIM, MATN2, HABP4, HAPLN1, HAS3,
COL16A1, CILP, COL6A3, GPC4, HAPLN1, and
ACAN
Catabolism MMP9, MMP3, CTSH, ADAMDEC1, and CTSS
Angiogenesis
STC1, PF4V1, EDNRB, AQP9, HBEGF,
BDKRB1, RCAN1, ECGF1, DNER, BDKRB2,
and PECAM1
PDGFC and RNH1
IL: Interleukin, TNFRS: tumour necrosis factor receptor, and IFI30: gene for encoding Gamma-interferon-inducible lysosomal thiol reductase. TNFAIP6:
tumor necrosis factor alpha-induced protein 6, IRF: interferon regulatory factor, CXCL: chemokine ligand, and ALOX5AP: 5-lipoxygenase activating protein
encoded by the ALOX5AP gene. PLD: phospholipase D1 enzyme that is encoded by the PLD1 gene, PTGES: prostaglandin E synthase is an enzyme encoded by
the PTGES gene, PLCB1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-1 is an enzyme encoded by the PLCB1 gene, and SOD2: superoxide
dismutase 2 enzyme encoded by the SOD2 gene. TBXAS1: thromboxane A synthase 1 enzyme encoded by the TBXAS1 gene, PI3: elafin, PLA2G4A: cytosolic
phospholipase A2 enzyme encoded by the PLA2G4A gene, TREM1: triggering receptor expressed on myeloid cells 1 protein encoded by the TREM1 gene,
S100A9: migration inhibitory factor-related protein 14, OSM: oncostatin M, PPARG: peroxisome proliferator-activated receptor gamma, HAS1: hyaluronan
synthases 1, BMP: bonemorphogenetic protein, COL: collagen, VIM: vimentin, MATN: cartilage matrix protein, HABP: hyaluronan-binding protein, HAPLN:
proteoglycan link protein, HAS: hyaluronan synthase, CILP: intermediate layer protein, GPC: cerebroglycan, ACAN: aggrecan, MMP: metalloproteinase,
CTSH: cathepsin H, ADAMDEC1: ADAM-like, decysin 1, CTSS: cathepsin S, STC1: stanniocalcin-1, EDNRB: endothelin receptor type B, AQP9: aquaporin-9,
HBEGF: heparin-binding EGF-like growth factor, BDKRB1: bradykinin receptor B1, RCAN1: Down syndrome critical region gene 1, ECGF1: platelet-derived
endothelial cell growth factor, DNER: Delta and Notch-like epidermal growth factor-related receptor, BDKRB2: bradykinin receptor B2, PECAM1: platelet
endothelial cell adhesion molecule, PDGFC: platelet-derived growth factor C, and RNH1: ribonuclease inhibitor.
clinical outcome or shorten the duration of the inflammatory
response after surgery.
4. Discussion
We have identified an expanding body of published literature
on synovitis in OA. This reflects a growing acceptance that
OA can no longer be considered a purely noninflammatory
condition and that synovitis is prevalent in OA patients. The
purpose of this review was to identify the pathophysiology
of the synovitis found in OA and to investigate the effect of
this synovial response on risk of progression and treatment
outcomes. In order to focus this study further, we assessed
only papers that included an intervention in the studied
population such as TKR or THR. Previous reviews have
focused on synovitis pathology in general or in the context
of OA but have not correlated imaging with histology or
assessed the correlation between presence on imaging and/or
histology with clinical symptoms.
We have observed a strong correlation between imaging
of the synovitis on MRI and histological findings. However,
there were two exceptions to this trend. In the Østergaard et
al. [9] study, MRI could not differentiate between moderate
and severe inflammation. This may be explained by the fact
that most patients in the study, in contrast to other studies,
had advanced disease with minimal overlap between histo-
logic groups.Thus, the differentiation between moderate and
severe inflammation was less distinct. In De Lange-Brokaar
et al.’s [19] study, MRI did not correlate with histological
findings. They used the validated Krenn et al. scoring system
used by other authors but did not use contrast enhancedMRI
as most other authors did.
The authors, Walther et al. [14, 15] and Waldstein et al.
[17], found that PDUS correlates well with histological grade
and has been shown to provide better correlation than MRI
with total synovitis score. As a consequence, these authors
have advocated the use of PDUS to detect joint synovitis.
There is less evidence for correlation of imaging or histo-
logical severity with clinical findings. In Liu et al.’s [11] study
of Japanese patients due to undergo TKR, neither imaging
or histology correlated with VAS or WOMAC scores. This
is contrary to De Lange-Brokaar’s [10] work that did show a
correlation betweenMRI synovitis score and VAS assessment
of pain. This is despite both studies finding a positive
correlation between MRI findings and histological synovitis.
Liu et al. [11] found only positive correlation between imaging
and histology with the preoperative JKOM score.The reasons
for this discrepancy are not clear. Most studies have found
a correlation with more mainstream scoring systems such as
VAS, WOMAC, KOOS, and the Intermittent and Constant
Osteoarthritis Pain (ICOAP). Interestingly, Okuda et al.’s [21]
earlier work had found no association betweenMRI synovitis
score and pain. However, De Lange-Brokaar’s earlier study
had less study participants and included only patients due for
arthroscopy rather than TKR.
Most studies identify that synovial tissue becomes
more inflamed as osteoarthritis progresses in severity. With
increasing OA severity, synovial membrane thickening,
increased macrophage infiltration, and vascular proliferation
are observed. However, Scanzello et al.’s study [24] has
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contradicted this finding. It is possible that differences in
patient selection underlie this discrepancy. It is also possible
that in Scanzello et al.’s study [24] the levels of inflammation
were generally lower than in other studies. Ayral et al.’s [29]
study shows evidence that the synovial inflammation profile
changes depending on the level of OA present. Different
patterns of synoviopathy with differences in tissue architec-
ture and inflammatory infiltrates characterise distinct stages
of OA. No studies commented on the presence of calcium
pyrophosphate dihydrate (CPPD) crystal deposition either
on haematoxylin and eosin staining or on polarised light
microscopy. It is likely that at least some samples did show
CPPD deposition disease given the often advanced state of
joint degeneration and so CPPD cannot be ruled out.
With regard to cytokines and chemokine expression,
there is less consensus within the literature. Many studies
indicate increased levels of IL-1𝛼, IL-1𝛽, TNF𝛼, and TGF𝛽
as OA progresses. However, there are other studies that have
shown no difference in Interleukin levels with the exception
of IL-15 [26] and IL-6 [27]. In another study, IL-1𝛽 levels
decreased in end stage OA compared to progressive OA [25].
It is not clear why there is no consensus within the literature
with regard to these findings. It may be due to differences in
patient populations or possibly the variable use of medica-
tions. In samples from the same patient gene expression, pat-
terns differ in tissues from inflamed and normal synovium,
suggesting upregulation of key inflammatory pathways that
could initiate or drive joint degeneration. Beyond the expres-
sion of cytokines, chemokines, and angiogenic compounds,
it is argued that the presence of synovial inflammation has
negative effects on cartilage integrity [19, 30].
To date, there is a paucity of studies showing how out-
comes are related to synovial inflammation in the context of
major joint replacement for OA.This is understandable since
research into the inflammatory component of OA is a rela-
tively newfield. Only a few papers investigated pain or PROM
scores and in all cases they were for preoperative assessments
only. Perhaps it is assumed that since THR or TKR are
definitive joint procedures then preoperative synovitis will
play little or no part. Further research is required to confirm
or refute this explanation.
5. Conclusion
In conclusion, synovitis is clearly present in OA, although
it has not been determined if this is inherent to the dis-
order or a complication of secondary CPPD. The exact
mechanisms are unknown and there is heterogeneity in the
literature with respect to the levels of particular cytokines
and inflammatory mediators within different stages of OA
degeneration. Most studies report either “early” or “late” OA
but it is not always clear what such a description means.
Many studies also had low numbers of study participants.
More research is needed with longitudinal studies applying
proven imaging modalities, histological analysis, and longer
follow-up. No studies have directly investigated the effect
of synovitis on postoperative outcomes or compared the
populations inwhich synovitis wasmore prevalent at the time
of surgical intervention. It is possible that synovitis is related
to other external factors and that this has an effect on clinical
symptoms and outcomes. Research into this field is relatively
new and will continue to define our understanding of the role
of synovitis in the pathogenesis of OA.
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